During the past decade, Montefiore Hutchinson Campus conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Montefiore Hutchinson Campus" are "Inflammatory Bowel Diseases" (2 trials), "Analgesia" (1 trials), "Anesthesia" (1 trials), "Crohn Disease" (1 trials) and "Depression, Anxiety" (1 trials). Many other conditions were trialed in "Montefiore Hutchinson Campus" in a lesser frequency.

Most popular intervention types in "Montefiore Hutchinson Campus" are "Drug" (3 trials), "Behavioral" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetaminophen" (2 trials), "0.25% bupivacaine" (1 trials), "BUZZY(tm)" (1 trials), "Digital mood tracking" (1 trials) and "Exparel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montefiore Hutchinson Campus" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Montefiore Hutchinson Campus". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Montefiore Hutchinson Campus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Montefiore Hutchinson Campus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".